On this page

Nominations

Massively parallel sequencing

In 2017, a nomination was received to establish a whole genome sequencing service using Massively Parallel Sequencing (MPS). MPS is a new technology for whole exome or whole genome sequencing and has a range of applications in the prenatal, neonatal, paediatric and adult settings.

Actions 

  • The establishment of sequencing infrastructure in the NSW public system was identified as a key component of achieving the goals laid out in the NSW Health Genomics Strategic Plan.
  • Funding was provided to purchase the MPS equipment and develop a brokerage model for the ordering of genetic and genomics tests.
  • A statewide service for whole genome and whole exome sequencing will be implemented. 

Neurofibromatosis service

In 2017, a nomination was received to establish a new hub and spoke clinic model for the management of patients with neurofibromatosis (NF). The committee recommended that additional advice be sought from stakeholders and NSW Health bodies.

Actions 

  • The committee recommended further analysis was required.
  • The hub and spoke service delivery model was considered an important initiative to develop and test new approaches to the delivery of genetic and genomic services.
  • Funding was provided to assist in the development, piloting and evaluation of a NSW hub and spoke service delivery model for NF. 

Point of care testing for chlamydia and gonorrhoea

In 2018 a nomination was received for a point of care test to detect chlamydia and gonorrhoea. This is a nucleic acid amplification test approved by the Therapeutic Goods Administration. Trials of this test in rural communities showed some benefits when compared to conventional testing.

Actions

  • The committee referred this technology to the NSW Health Pathology point of care expert panel for assessment for possible introduction into the NSW Health system.​​​​

Contact

New health technology enquiries can be emailed to: MOH-HealthTechNominations@health.nsw.gov.au
Current as at: Wednesday 25 November 2020
Contact page owner: Strategic Reform and Planning